Schedule 13G ownership disclosure
LARIMAR THERAPEUTICS INC
Security class unavailable · CUSIP: 517125100
Event date: 2020-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 145,883
- Percent of class
- 1.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-014711
- Form type
- SC 13G
- Filer
- Larimar Therapeutics, Inc.
- CIK
- CIK 1374690
- Filed
- Jun 11, 2020
- Reporting period
- Jun 01, 2020
- Description
- Schedule 13G beneficial ownership